Inhibition of Cell Growth and DNA, RNA, and Protein Synthesis in Vitro by Fentanyl, Sufentanil, and Opiate Analgesics
dc.contributor.author | Nassiri, M. Reza | en_US |
dc.contributor.author | Flynn, Gordon L. | en_US |
dc.contributor.author | Shipman, Charles Jr. | en_US |
dc.date.accessioned | 2010-06-01T21:20:02Z | |
dc.date.available | 2010-06-01T21:20:02Z | |
dc.date.issued | 1991-07 | en_US |
dc.identifier.citation | Nassiri, M. Reza; Flynn, Gordon L.; Shipman, Charles (1991). "Inhibition of Cell Growth and DNA, RNA, and Protein Synthesis in Vitro by Fentanyl, Sufentanil, and Opiate Analgesics." Pharmacology & Toxicology 69(1): 17-21. <http://hdl.handle.net/2027.42/74401> | en_US |
dc.identifier.issn | 0901-9928 | en_US |
dc.identifier.issn | 1600-0773 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74401 | |
dc.description.abstract | We have studied the cytotoxic nature of two groups of narcotic analgesics. Group I consists of the opioids, morphine, codeine, hydromorphone, thebaine, and etorphine. Group II contains but two phenylpiperidine-type narcotics, fentanyl and sufentanil. To measure cytotoxicity, three different bioassays were employed using an established line of human cells. Specifically, the effects of narcotic analgesics on DNA, RNA, and protein synthesis were measured by following the uptake and incorporation of radiolabeled thymidine, uridine, and amino acids, respectively. Inhibition of cell growth also was studied by measuring population doubling times of logarithmically growing cells in the presence (or absence) of the test compounds. Lastly, cloning efficiencies of cells were determined in the presence of both groups of compounds. Group I compounds were significantly less inhibitory than Group II compounds by all three bioassays. Moreover, flow cytometric DNA analysis of cells treated with 100 and 320 ΜM etorphine HC1 showed essentially no effects on cell cycle distribution. These in vitro results thus suggest that (1) fentanyl and sufentanil are inherently more cytotoxic than the opioid narcotics in Group I, and (2) the highly potent morphinoid drug etorphine HCl appears to have special promise as a transdermal narcotic to control pain. | en_US |
dc.format.extent | 463955 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1991 Nordic Pharmacological Society | en_US |
dc.title | Inhibition of Cell Growth and DNA, RNA, and Protein Synthesis in Vitro by Fentanyl, Sufentanil, and Opiate Analgesics | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Biologic and Materials Sciences, School of Dentistryr, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationum | College of Pharmacyr, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Microbiology and Immunology, School of Medicine, The University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.identifier.pmid | 1719515 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74401/1/j.1600-0773.1991.tb00402.x.pdf | |
dc.identifier.doi | 10.1111/j.1600-0773.1991.tb00402.x | en_US |
dc.identifier.source | Pharmacology & Toxicology | en_US |
dc.identifier.citedreference | Barlogie, B., M. N. Raber, J. Johnnes, T. S. Johnson, B. Drewinko, D. W. Swartzendruber, W. Gohde, M. Andreef & E. J. Freireich: Flow cytometry in clinical cancer research. Cancer Res. 1983, 43, 3982 – 3997. | en_US |
dc.identifier.citedreference | Blane, G. F., L. A. Boura, A. E. Fitzgerald & R. E. Lister: Actions of etorphine hydrochloride (M99). Brit. J. Pharmacol. Chemotherap, 1967, 30, 11 – 22. | en_US |
dc.identifier.citedreference | Blane, G. F. & D. S. Robbie: Trial of etorphine (M99 Reckitt) in carcinoma pain: preliminary report. Proc. Brit. Pharmacol. Soc. 1970, 39, 252 – 253. | en_US |
dc.identifier.citedreference | Chatton, M. J.: Pain. In: Current medical diagnosis and treatment. Eds.: M. A. Krupp and M. J. Chatton. Lange Medical Publishers, Los Altos, California, 1982, pp. 9 – 13. | en_US |
dc.identifier.citedreference | Flynn, G. L., W. M. Smith & T. A. Hagen: In vitro transport. In: Transdermal delivery of drugs. Eds.: A. F. Kydonieus and B. Berner. CRC Press, Boca Raton, Florida, 1987, Vol. 1, pp. 45 – 59. | en_US |
dc.identifier.citedreference | Goldstein, A.: Biostatistics, an introductory text. MacMillan Co., New York, 1964, pp. 156 – 161. | en_US |
dc.identifier.citedreference | Hayflick, L.: Screening tissue cultures for mycoplasma infections. In: Tissue culture: Methods and applications. Eds.: P. F. Kruse, Jr. and M. K. Patterson. Academic Press, New York, 1973, pp. 722 – 728. | en_US |
dc.identifier.citedreference | Holley, F. O. & C. Van Steenis: Transdermal administration of fentanyl for postoperative analgesia. Anesthesiol. 1984, 65, A548. | en_US |
dc.identifier.citedreference | Hydro, W. R.: Process of purifying oripavines. U.S. Patent No. 3, 763, 167, issued October 2, 1973. | en_US |
dc.identifier.citedreference | Laerum, D. O. & T. Farsund: Clinical application of flow cytometry: a review. Cytometry 1981: 2, 1 – 13. | en_US |
dc.identifier.citedreference | Lipman, A. G.: Drug therapy in cancer pain. Cancer Nurs. 1980, 3, 39 – 46. | en_US |
dc.identifier.citedreference | Nassiri, M. R., J. L. Hudson, J. S. Pudlo, G. M. Birch, L. B. Townsend & J. C. Drach: Flow cytometric evaluation of the cytotoxicity of novel antiviral compounds. Cytometry 1990, 11, 411 – 417. | en_US |
dc.identifier.citedreference | Schols, D., R. Pauwels, J. Desmyter & E. De Clercq: Flow cytometric method to monitor the destruction of CD + cells following their fusion with HIV-infected cells. Cytometry 1990, 11, 736 – 743. | en_US |
dc.identifier.citedreference | Shipman, C. Jr.: Evaluation of 4-(2-hydroxyethyl)-1-piperazineËtha-ne sulfonic acid (HEPES) as a tissue culture buffer. Proc. Soc. Exp. Biol. Med. 1969, 130, 305 – 310. | en_US |
dc.identifier.citedreference | Shipman, C. Jr., M. R. Nassiri & G. L. Flynn: U.S. Patent Transdermal delivery of the narcotic analgesics etorphine and analogs, No. 4,c 891,377, issued Jan. 2, 1990. | en_US |
dc.identifier.citedreference | Turk, S. R., C. Shipman, Jr., M. R. Nassiri, G. Genzlinger, S. Krawczyk, L. B. Townsend & J. C. Drach: Pyrrolo [2,3-d] pyrim-idine nucleosides as inhibitors of human cytomegalovirus. Anti-micro. Agents Chemotherap. 1987, 31, 544 – 550. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.